Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 4 studies | 21% ± 4% | |
| oligodendrocyte precursor cell | 4 studies | 25% ± 7% | |
| astrocyte | 4 studies | 24% ± 9% | |
| oligodendrocyte | 4 studies | 20% ± 5% | |
| epithelial cell | 3 studies | 25% ± 5% | |
| GABAergic neuron | 3 studies | 41% ± 5% | |
| glutamatergic neuron | 3 studies | 56% ± 5% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 39% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 562.63 | 2639 / 2642 | 100% | 7.93 | 705 / 705 |
| esophagus | 100% | 472.09 | 1438 / 1445 | 100% | 4.50 | 183 / 183 |
| lung | 100% | 449.07 | 576 / 578 | 100% | 4.25 | 1153 / 1155 |
| breast | 100% | 590.18 | 459 / 459 | 99% | 5.63 | 1112 / 1118 |
| ovary | 100% | 471.64 | 180 / 180 | 99% | 3.53 | 426 / 430 |
| pancreas | 100% | 495.69 | 328 / 328 | 99% | 3.89 | 176 / 178 |
| prostate | 100% | 465.48 | 244 / 245 | 99% | 4.08 | 498 / 502 |
| kidney | 100% | 398.93 | 89 / 89 | 99% | 4.37 | 889 / 901 |
| uterus | 100% | 555.40 | 170 / 170 | 98% | 3.98 | 450 / 459 |
| thymus | 100% | 559.17 | 652 / 653 | 98% | 4.10 | 594 / 605 |
| intestine | 100% | 534.78 | 966 / 966 | 98% | 3.54 | 516 / 527 |
| stomach | 100% | 444.58 | 358 / 359 | 97% | 3.74 | 278 / 286 |
| bladder | 100% | 488.57 | 21 / 21 | 97% | 3.44 | 488 / 504 |
| adrenal gland | 100% | 477.28 | 257 / 258 | 97% | 5.17 | 222 / 230 |
| skin | 100% | 651.07 | 1807 / 1809 | 94% | 5.06 | 444 / 472 |
| liver | 100% | 286.08 | 226 / 226 | 90% | 2.28 | 364 / 406 |
| adipose | 100% | 544.81 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 614.69 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 100% | 460.75 | 241 / 241 | 0% | 0 | 0 / 0 |
| muscle | 100% | 649.80 | 802 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 3.59 | 44 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 3.38 | 28 / 29 |
| heart | 94% | 422.31 | 811 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 81% | 2.47 | 65 / 80 |
| peripheral blood | 39% | 199.28 | 360 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0032781 | Biological process | positive regulation of ATP-dependent activity |
| GO_0061077 | Biological process | chaperone-mediated protein folding |
| GO_0017183 | Biological process | protein histidyl modification to diphthamide |
| GO_0005856 | Cellular component | cytoskeleton |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0008198 | Molecular function | ferrous iron binding |
| GO_0008270 | Molecular function | zinc ion binding |
| GO_0001671 | Molecular function | ATPase activator activity |
| Gene name | DNAJC24 |
| Protein name | DnaJ homolog subfamily C member 24 (CSL-type zinc finger-containing protein 3) (Diphthamide biosynthesis protein 4) DnaJ heat shock protein family (Hsp40) member C24 |
| Synonyms | DPH4 ZCSL3 |
| Description | FUNCTION: Stimulates the ATPase activity of several Hsp70-type chaperones. This ability is enhanced by iron-binding. The iron-bound form is redox-active and can function as electron carrier. Plays a role in the diphthamide biosynthesis, a post-translational modification of histidine which occurs in translation elongation factor 2 (EEF2) which can be ADP-ribosylated by diphtheria toxin and by Pseudomonas exotoxin A (Eta). . |
| Accessions | E9PID3 ENST00000395949.2 E9PRW3 ENST00000525511.5 ENST00000526529.3 J3KPT8 ENST00000465995.6 [Q6P3W2-1] ENST00000526042.5 [Q6P3W2-2] H0YCV1 Q6P3W2 ENST00000527731.1 |
